BNTX 96.74 ▼ -7.26% Live Trading Data - Stocknear

BioNTech SE

NASDAQ: BNTX · Real-Time Price · USD
96.74
-7.57 (-7.26%)
At close: Sep 12, 2025, 3:59 PM
96.89
0.16%
After-hours: Sep 12, 2025, 07:56 PM EDT
-7.26%
Bid 96.47
Market Cap 23.26B
Revenue (ttm) 2.88B
Net Income (ttm) -347.44M
EPS (ttm) -1.69
PE Ratio (ttm) -57.24
Forward PE -23.88
Analyst Buy
Ask 96.98
Volume 5,061,150
Avg. Volume (20D) 756,174
Open 102.55
Previous Close 104.31
Day's Range 90.12 - 102.55
52-Week Range 81.20 - 131.49
Beta 1.40

About BNTX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BNTX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for BNTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

BioNTech SE is scheduled to release its earnings on Nov 3, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
1 day ago
Vaccine stocks are trading lower after a report in... Unlock content with Pro Subscription
5 days ago
-8.71%
BioNTech shares are trading lower. The company and Bristol Myers Squibb presented interim data from global randomized phase 2 trial evaluating Pumitamig an investigational bispecific antibody targeting PD-L1 X VEGF-A, plus chemotherapy in ES-SCLC patients.